EMD Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial - 14th Apr 2022, 9:47am

annb0t

annb0t

Top 20
EMD Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
Price Sensitive: N
Date: 14th Apr 2022, 9:47am

>>> Read announcement: Google: EMD Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
EMD Ann: Results of General Meeting - 31st Oct 2023, 3:43pm
Replies
0
Views
79
annb0t
annb0t
annb0t
EMD Ann: Emyria Secures Ethics Endorsement for MDMA AP Application - 30th Oct 2023, 9:23am
Replies
0
Views
67
annb0t
annb0t
annb0t
EMD Ann: ASA Virtual Investor Summit Presentation October 2023 - 27th Oct 2023, 8:04am
Replies
0
Views
130
annb0t
annb0t
annb0t
EMD Ann: September 2023 Quarterly Activities Report and Appendix 4C - 26th Oct 2023, 10:29am
Replies
0
Views
69
annb0t
annb0t
annb0t
EMD Ann: Change in substantial holding - 24th Oct 2023, 12:28pm
Replies
0
Views
68
annb0t
annb0t
Top Bottom